Phase 3 / Commercialization

Get a complete overview of TraceLink's mission, product portfolio, partner and customer landscape, and life sciences industry recognition.

Hear how addressing serialization well before your PDUFA date minimizes risk to your commercial launch.

If you're a Phase 3 pharma company, serialization will be part of your strategy. Watch Sharp SVPs discuss how they approach serialization.

Polls show that 82% of clinical-stage virtual pharma companies, uncertain about the impact of serialization, are preparing for DSCSA compliance now.

See how Excellis Health Solutions avoids bottlenecks in serialization implementation, DSCSA challenges, and their philosophy behind phase 3 planning.

See why clinical-stage pharma companies must learn basic DSCSA serialization requirements—or risk years of work and millions of dollars.